Copyright
©The Author(s) 2017.
World J Gastrointest Oncol. Aug 15, 2017; 9(8): 333-340
Published online Aug 15, 2017. doi: 10.4251/wjgo.v9.i8.333
Published online Aug 15, 2017. doi: 10.4251/wjgo.v9.i8.333
Table 3 Objective response rates and toxicity composite endpoint n (%)
| Adeno | SCC | |
| No. of patients | 841 | 132 |
| Complete response | 48 (6) | 7 (5) |
| Partial response | 323 (38) | 36 (27) |
| Stable disease | 224 (30) | 35 (27) |
| Progressive disease | 157 (19) | 38 (29) |
| Objective response rate (95%CI) | 371 (44) 41%-48% | 43 (33) 25%-41% P = 0.01 |
| Toxicity composite endpoint (95%CI) | 381 (45) 42%-49% | 58 (44) 35%-53% P = 0.77 |
- Citation: Davidson M, Chau I, Cunningham D, Khabra K, Iveson T, Hickish T, Seymour M, Starling N. Impact of tumour histological subtype on chemotherapy outcome in advanced oesophageal cancer. World J Gastrointest Oncol 2017; 9(8): 333-340
- URL: https://www.wjgnet.com/1948-5204/full/v9/i8/333.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v9.i8.333